UB Paderborn / Katalog / Suche / in CDI

The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data

Therapeutic innovation & regulatory science, 2024-05, Vol.58 (3), p.443-455

2024

Link zum Volltext

Verfügbarkeit prüfen

Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care

Cancer informatics, 2019, Vol.18, p.1176935119835538-1176935119835538

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient Characteristics and Treatment Patterns in the First-Line and Second-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the United Kingdom, France, and Germany

Blood, 2018-11, Vol.132 (Supplement 1), p.4234-4234

2018

Link zum Volltext

Verfügbarkeit prüfen

Recurring event survival analyses: A methodological approach to model recurring event data in cancer patients receiving multiple lines of therapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18693-e18693

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessment of early and late symptom toxicity in a real-world cancer treatment population using the PRO-CTCAE

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18663-e18663

2022

Link zum Volltext

Verfügbarkeit prüfen

A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

Journal of patient-reported outcomes, 2019-06, Vol.3 (1), p.35-35, Article 35

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-07-04: Evaluation of Treatment Choices at Baseline Among Breast Cancer Patients Based on the Frailty Status of the Patients

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-07-04

2023

Link zum Volltext

Verfügbarkeit prüfen

Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States

PharmacoEconomics - open, 2019-06, Vol.3 (2), p.237-245

2019

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia By Cytogenetic Risk and Treatment Status

Blood, 2022-11, Vol.140 (Supplement 1), p.7959-7960

2022

Link zum Volltext

Verfügbarkeit prüfen

Estimating Relationships between Response, Progression, and Survival in Relapsed-Refractory Multiple Myeloma in Pooled Clinical Trials Database

Blood, 2019-11, Vol.134 (Supplement_1), p.5900-5900

2019

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review

Melanoma management, 2018-03, Vol.5 (1), p.MMT01-MMT01

2018

Link zum Volltext

Verfügbarkeit prüfen

Sa1190: REAL WORLD COMPARISON OF HEALTHCARE RESOURCE UTILIZATION BETWEEN TRANSORAL INCISIONLESS FUNDOPLICATION AND LAPAROSCOPIC NISSEN FUNDOPLICATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-338-S-339

2022

Link zum Volltext

Verfügbarkeit prüfen

REAL WORLD COMPARISON OF THE CHARACTERISTICS OF PATIENTS WHO RECEIVED TRANSORAL INCISIONLESS FUNDOPLICATION VS. LAPAROSCOPIC NISSEN FUNDOPLICATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

Gastrointestinal endoscopy, 2022-06, Vol.95 (6), p.AB411-AB411

2022

Link zum Volltext

Verfügbarkeit prüfen

Dynamic Changes in International Staging System As a Predictor of Survival Outcome in Patients with Advanced Multiple Myeloma

Blood, 2018-11, Vol.132 (Supplement 1), p.4438-4438

2018

Link zum Volltext

Verfügbarkeit prüfen

Assessment of vitamin D deficiency and COVID-19 diagnosis in patients with breast or prostate cancer using electronic medical records

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6589-6589

2021

Link zum Volltext

Verfügbarkeit prüfen

Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA

International journal of clinical practice (Esher), 2016-12, Vol.70 (12), p.1012-1018

2016

Link zum Volltext

Verfügbarkeit prüfen

Racial Differences in Multiple Myeloma Survival and Treatment Using Pooled Clinical Trial and Real-World Electronic Medical Record Data

Blood, 2020-11, Vol.136 (Supplement 1), p.9-9

2020

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Hematologic Function and Cytokine Release Syndrome Severity in ALL Patients Receiving CAR-T and TCR-T Therapies Using Pooled Clinical Trial Data

Blood, 2021-11, Vol.138 (Supplement 1), p.4826-4826

2021

Link zum Volltext

Verfügbarkeit prüfen

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Blood, 2019-11, Vol.134 (Supplement_1), p.4895-4895

2019

Link zum Volltext

Verfügbarkeit prüfen

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma

Oncotarget, 2019-05, Vol.10 (35), p.3285-3293

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-07-12: Patient-Reported Symptom Burden in Women Undergoing Treatment for Early Stage and Metastatic Breast Cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P5-P5-07-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessing the relationship in relapsed-refractory multiple myeloma between response, progression, and survival between pooled clinical trial subjects and a real-world electronic medical record data source

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20525-e20525

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluating progression-free survival in black and white women with triple-negative breast cancer in pooled clinical trials from a synthetic control database (SCD) and real-world electronic medical records (EMR)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e13102-e13102

2020

Link zum Volltext

Verfügbarkeit prüfen

Economic Impact and Healthcare Utilization in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Routine Clinical Care in the United States (US) - a Claims Database Study

Blood, 2017-12, Vol.130, p.2185-2185

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment Patterns in Newly Treated and Relapse/Refractory Patients with Follicular Lymphoma in Routine Clinical Care — a United States Electronic Medical Record Database Study

Blood, 2017-12, Vol.130, p.4059-4059

2017

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The Next Horizon of Drug Development: External Control Arms and Innovative Tools to Enrich Clinical Trial Data

Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care

Patient Characteristics and Treatment Patterns in the First-Line and Second-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the United Kingdom, France, and Germany

Recurring event survival analyses: A methodological approach to model recurring event data in cancer patients receiving multiple lines of therapy

Assessment of early and late symptom toxicity in a real-world cancer treatment population using the PRO-CTCAE

A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

Abstract P5-07-04: Evaluation of Treatment Choices at Baseline Among Breast Cancer Patients Based on the Frailty Status of the Patients

Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States

Feasibility of Real-World Assessment of Patient-Reported Outcomes in Acute Myeloid Leukemia By Cytogenetic Risk and Treatment Status

Estimating Relationships between Response, Progression, and Survival in Relapsed-Refractory Multiple Myeloma in Pooled Clinical Trials Database

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review

Sa1190: REAL WORLD COMPARISON OF HEALTHCARE RESOURCE UTILIZATION BETWEEN TRANSORAL INCISIONLESS FUNDOPLICATION AND LAPAROSCOPIC NISSEN FUNDOPLICATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

REAL WORLD COMPARISON OF THE CHARACTERISTICS OF PATIENTS WHO RECEIVED TRANSORAL INCISIONLESS FUNDOPLICATION VS. LAPAROSCOPIC NISSEN FUNDOPLICATION FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

Dynamic Changes in International Staging System As a Predictor of Survival Outcome in Patients with Advanced Multiple Myeloma

Assessment of vitamin D deficiency and COVID-19 diagnosis in patients with breast or prostate cancer using electronic medical records

Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA

Racial Differences in Multiple Myeloma Survival and Treatment Using Pooled Clinical Trial and Real-World Electronic Medical Record Data

Patterns of Hematologic Function and Cytokine Release Syndrome Severity in ALL Patients Receiving CAR-T and TCR-T Therapies Using Pooled Clinical Trial Data

Real-World Rates and Management of Thrombocytopenia Due to Cancer Treatment in Advanced/Metastatic Female Genitourinary Malignancies

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma

Abstract P5-07-12: Patient-Reported Symptom Burden in Women Undergoing Treatment for Early Stage and Metastatic Breast Cancer

Assessing the relationship in relapsed-refractory multiple myeloma between response, progression, and survival between pooled clinical trial subjects and a real-world electronic medical record data source

Evaluating progression-free survival in black and white women with triple-negative breast cancer in pooled clinical trials from a synthetic control database (SCD) and real-world electronic medical records (EMR)

Economic Impact and Healthcare Utilization in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in Routine Clinical Care in the United States (US) - a Claims Database Study

Treatment Patterns in Newly Treated and Relapse/Refractory Patients with Follicular Lymphoma in Routine Clinical Care — a United States Electronic Medical Record Database Study

Suchergebnisse filtern